Search Results - Beate Weidenthaler-Barth
- Showing 1 - 4 results of 4
-
1
The Role of the Immune Phenotype in Tumor Progression and Prognosis of Patients with Mycosis Fungoides: A Quantitative Immunohistology Whole Slide Approach by Natallia Aulasevich, Maximilian Haist, Sebastian Försch, Beate Weidenthaler-Barth, Volker Mailänder
Published in Cells (2022-11-01)Get full text
Article -
2
Ocrelizumab-induced vulvovaginal pyoderma gangrenosum in a patient with relapsing-remitting multiple sclerosis by Annika Klumpp, MD, Felix Luessi, MD, Sinah Engel, MD, Beate Weidenthaler-Barth, MD, Detlef Becker, MD, Stephan Grabbe, MD, Hadrian Schepler, MD
Published in JAAD Case Reports (2022-10-01)Get full text
Article -
3
Analytical Validation of an Immunohistochemical 7-Biomarker Prognostic Assay (immunoprint<sup>®</sup>) for Early-Stage Cutaneous Melanoma in Archival Tissue of Patients with AJCC v... by Mirjana Ziemer, Beate Weidenthaler-Barth, Philipp Gussek, Maja Pfeiffer, Johannes Kleemann, Katrin Bankov, Peter J. Wild, Silke Seibold, Priyavathi Sureshkumar, Patricia Nickel, Anton Strobel, Markus Werner, Stephan Grabbe
Published in Diagnostics (2023-09-01)Get full text
Article -
4
Constitutive expression of the transcriptional co-activator IκBζ promotes melanoma growth and immunotherapy resistance by Antonia Kolb, Ana-Marija Kulis-Mandic, Matthias Klein, Anna Stastny, Maximilian Haist, Vanessa Votteler, Beate Weidenthaler-Barth, Tobias Sinnberg, Antje Sucker, Gabriele Allies, Lea Jessica Albrecht, Alpaslan Tasdogan, Andrea Tuettenberg, Matthias M. Gaida, Carsten Deppermann, Henner Stege, Dirk Schadendorf, Stephan Grabbe, Klaus Schulze-Osthoff, Daniela Kramer
Published in Nature Communications (2025-06-01)Get full text
Article
